NFA
ARRY

Nationwide Fund Advisors’s Array Biopharma Inc ARRY Stock Holding History

Nationwide Fund Advisors’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-380,713
Closed -$4.68M – 2798
2017
Q3 		$4.68M Buy
380,713
+254,720
+202% +$2.37M 0.02% 1048
2017
Q2 		$1.05M Buy
125,993
+14,254
+13% +$117K ﹤0.01% 1751
2017
Q1 		$999K Sell
111,739
-27,528
-20% -$293K ﹤0.01% 1746
2016
Q4 		$1.22M Buy
139,267
+11,479
+9% +$84.5K 0.01% 1662
2016
Q3 		$863K Buy
127,788
+36,661
+40% +$142K ﹤0.01% 1875
2016
Q2 		$324K Hold
91,127
– – ﹤0.01% 2378
2016
Q1 		$269K Sell
91,127
-1,400
-2% -$4.2K ﹤0.01% 2404
2015
Q4 		$390K Buy
92,527
+984
+1% +$4.49K ﹤0.01% 2242
2015
Q3 		$417K Hold
91,543
– – ﹤0.01% 2220
2015
Q2 		$660K Sell
91,543
-4,341
-5% -$32K ﹤0.01% 2088
2015
Q1 		$707K Buy
95,884
+499
+0.5% +$3.55K ﹤0.01% 2076
2014
Q4 		$451K Sell
95,385
-2,093
-2% -$8.28K ﹤0.01% 2238
2014
Q3 		$348K Sell
97,478
-432
-0.4% -$1.7K ﹤0.01% 2418
2014
Q2 		$446K Buy
97,910
+2,157
+2% +$8.92K ﹤0.01% 2325
2014
Q1 		$450K Sell
95,753
-19,382
-17% -$97.5K ﹤0.01% 2104
2013
Q4 		$577K Buy
115,135
+2,327
+2% +$12.7K ﹤0.01% 2183
2013
Q3 		$702K Buy
112,808
+24,078
+27% +$143K ﹤0.01% 2042
2013
Q2 		$403K Buy
+88,730
New +$477K ﹤0.01% 2115

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Nationwide Fund Advisors's ARRY Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Array Biopharma Inc (ARRY) in Q4 2017, closing a stake of 380,713 shares — an estimated $4.68M sold.

Nationwide Fund Advisors first reported a position in ARRY in Q2 2013 and held it in 18 quarters. The position peaked at $4.68M in Q3 2017. 191 funds tracked by Wall St. Rank hold ARRY as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Array Biopharma Inc position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 380,713 Array Biopharma Inc shares in Q4 2017, an estimated $4.68M.
  • Nationwide Fund Advisors first reported a position in Array Biopharma Inc in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's Array Biopharma Inc position peaked at $4.68M in Q3 2017.
  • 191 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.